Projects Portfolio
Selected collaborations across drug discovery, spatial transcriptomics, and omics analytics where our platform supports discovery from data to candidate.
Antibiotics Discovery
Antibiotics Discovery
In collaboration with academic researchers, we design AI-generated small molecules to tackle antibiotic resistance. Our platform integrates generative models, structure-based docking, and in-silico validation to accelerate early discovery and prioritize compounds with real translational potential.
Why we care: Antimicrobial resistance is a top global health threat, making routine infections and procedures riskier.[1] In 2019, bacterial AMR caused 1.27 million deaths directly, with 4.95 million associated deaths worldwide.[2] In the U.S., resistant infections cause at least 2.8 million illnesses and 35,000 deaths each year.[3]